The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Open accessAbstract
Mutations in the gene encoding the transcriptional repressor methyl-CpG binding protein 2 (MeCP2) cause the neurodevelopmental disorder Rett syndrome. Loss of function as well as increased dosage of the MECP2 gene cause a host of neuropsychiatric disorders. To explore the molecular mechanism(s) underlying these disorders, we examined gene expression patterns in the hypothalamus of mice that either lack or overexpress MeCP2. In both models, MeCP2 dysfunction induced changes in the expression levels of thousands of genes, but unexpectedly the majority of genes (∼85%) appeared to be activated by MeCP2. We selected six genes and confirmed that MeCP2 binds to their promoters. Furthermore, we showed that MeCP2 associates with the transcriptional activator CREB1 at the promoter of an activated target but not a repressed target. These studies suggest that MeCP2 regulates the expression of a wide range of genes in the hypothalamus and that it can function as both an activator and a repressor of transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While Mecp2 mutant mice are an excellent model for RTT, elimination of MeCP2 affects the expression of a profound number of pathways in the CNS, making it difficult to pinpoint which ones play a key role in pathology [77,89,90].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, MeCP2 may also facilitate transcriptional activation [77], chromatin compaction [78,79] and mRNA splicing [80,81], while also interacting with a host of other regulatory proteins involved in a variety of molecular pathways [81–84].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Altogether, multiple studies suggest that genes can be activated or repressed by MeCP2, depending upon the cellular context [77,89,90], suggesting that MeCP2 may be defined as a transcriptional modulator.”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
In the citing paper
“These data are consistent with another study showing that MeCP2 binding to methylated DNA has a biphasic impact on transcription.”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Self-citationNan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,791
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J., & Zoghbi, H. Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh282 · Cited by 626
Self-citationThe disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
Chang, Q., Khare, G., Dani, V., Nelson, S., & Jaenisch, R. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.027 · Cited by 578
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- C. L. Martinet al., Am. J. Med. Genet. B. Neuropsychiatr. Genet.144, 869 (2007).
- H. Caldeira Araujoet al., Am. J. Med. Genet. A.133, 122 (2005).
- We thank members of the Zoghbi laboratory for their thoughtful comments Z. Yin for technical assistance M. Shinawi and A. Tawil for technical advice Y. Klisch for the art work and J. Lim J. Neul and M. Greenberg for reagents. The Baylor College of Medicine Microarray Core Facility performed the microarray experiments. This work was funded by NIH/National Institute of Neurological Disorders and Stroke grant NS057819 (H.Z.) National Institute of Child Health and Human Development Mental Retardation and Developmental Disabilities Research Center HD024064 (H.Z.) the International Rett Syndrome Foundation and the Simons Foundation. H.Z. is a Howard Hughes Medical Institute investigator. The microarray data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo) and are accessible through GEO Series accession number GSE11150.
Cited by
Sorted by citations
Items 301–400 of 999
MeCP2 and Rett syndrome: reversibility and potential avenues for therapy
Gadalla, K. K. E., Bailey, M. E. S., & Cobb, S. (2011) · Biochemical Journal · doi:10.1042/bj20110648 · Cited by 101
Mouillet‐Richard, S., Baudry, A., Launay, J., & Kellermann, O. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.035 · Cited by 98
Adkins, N. L., & Georgel, P. T. (2011) · Biochemistry and Cell Biology · doi:10.1139/o10-112 · Cited by 104
Ballestas, M. E., & Kaye, K. M. (2011) · Future Microbiology · doi:10.2217/fmb.11.137 · Cited by 98
MECP2 regulates cortical plasticity underlying a learned behaviour in adult female mice
Krishnan, K., Lau, B. Y. B., Ewall, G., Huang, Z. J., & Shea, S. D. (2017) · Nature Communications · doi:10.1038/ncomms14077 · Cited by 105
Tsujimura, K., Abematsu, M., Kohyama, J., Namihira, M., & Nakashima, K. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.001 · Cited by 99
Borghese, B., Barbaux, S., Mondon, F., Santulli, P., Pierre, G., Vinci, G., Chapron, C., & Vaiman, D. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0160 · Cited by 97
McClelland, S., Kőrösi, A., Cope, J. L., Ivy, A. S., & Baram, T. Z. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.008 · Cited by 101
Filippis, B. D., Fabbri, A., Simone, D., Canese, R., Ricceri, L., Malchiodi‐Albedi, F., Laviola, G., & Fiorentini, C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.301 · Cited by 100
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
Pejhan, S., & Rastegar, M. (2021) · Biomolecules · doi:10.3390/biom11010075 · Cited by 100
Rochman, M., Postnikov, Y. V., Correll, S., Malicet, C., Wincovitch, S., Karpova, T., McNally, J. G., Wu, X., Bubunenko, N. A., Grigoryev, S. A., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.002 · Cited by 101
Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C
Nowakowska, B., Obersztyn, E., Szymańska, K., Bekiesińska‐Figatowska, M., Xia, Z., Ricks, C. B., Bocian, E., Stockton, D. W., Szczałuba, K., Nawara, M., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31071 · Cited by 97
Dendritic spine dysgenesis in Rett syndrome
Xu, X., Miller, E. C., & Pozzo‐Miller, L. D. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00097 · Cited by 98
Zachariah, R. M., & Rastegar, M. (2012) · Neural Plasticity · doi:10.1155/2012/415825 · Cited by 103
Many paths to one goal? The proteins that recognize methylated DNA in eukaryotes
Sasai, N., & Defossez, P. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082652ns · Cited by 108
Linking MECP2 and pain sensitivity: The example of Rett syndrome
Downs, J. A., Géranton, S. M., Bebbington, A., Jacoby, P. A., Bahi‐Buisson, N., Ravine, D., & Leonard, H. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33314 · Cited by 100
The role of oxidative stress in Rett syndrome: an overview
Felice, C. D., Signorini, C., Leoncini, S., Pecorelli, A., Durand, T., Valacchi, G., Ciccoli, L., & Hayek, J. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06611.x · Cited by 95
Wood, L., Gray, N. W., Zhou, Z., Greenberg, M. E., & Shepherd, G. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3321-09.2009 · Cited by 93
Gonzales, M. L., Adams, S., Dunaway, K. W., & LaSalle, J. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06728-11 · Cited by 95
MECP2, a multi-talented modulator of chromatin architecture
Ragione, F. D., Vacca, M., Fioriniello, S., Pepe, G., & D’Esposito, M. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw023 · Cited by 95
Prospects for the development of epigenetic drugs for CNS conditions
Szyf, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4580 · Cited by 96
Roth, T. L. (2013) · Development and Psychopathology · doi:10.1017/s0954579413000618 · Cited by 95
Chromatin regulation in drug addiction and depression
Renthal, W. R., & Nestler, E. J. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/wrenthal · Cited by 92
Unlocking epigenetic codes in neurogenesisPreprint
Yao, B., & Jin, P. (2014) · Genes & Development · doi:10.1101/gad.241547.114 · Cited by 97
Emerging roles for MEF2 in brain development and mental disorders
Assali, A., Harrington, A. J., & Cowan, C. W. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.04.008 · Cited by 92
Epigenetic mechanisms in pubertal brain maturation
Morrison, K. E., Rodgers, A. B., Morgan, C. P., & Bale, T. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.014 · Cited by 97
A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons
Lin, Y., Frei, J. A., Kilander, M. B. C., Shen, W., & Blatt, G. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00263 · Cited by 97
An inside job: how endosomal Na+/H+ exchangers link to autism and neurological disease
Kondapalli, K. C., Prasad, H., & Rao, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00172 · Cited by 97
Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism
Swanberg, S. E., Nagarajan, R. P., Peddada, S., Yasui, D. H., & LaSalle, J. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn380 · Cited by 95
Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
Nance, E. A., Kambhampati, S. P., Smith, E. S., Zhang, Z., Zhang, F., Singh, S., Johnston, M. V., Kannan, R. M., Blue, M. E., & Kannan, S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1004-5 · Cited by 96
Andoh-Noda, T., Akamatsu, W., Miyake, K., Matsumoto, T., Yamaguchi, R., Sanosaka, T., Okada, Y., Kobayashi, T., Ohyama, M., Nakashima, K., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0121-2 · Cited by 92
Genetic disorders associated with postnatal microcephaly
Seltzer, L. E., & Paciorkowski, A. R. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31400 · Cited by 91
Alcohol exposure during development: Impact on the epigenome
Perkins, A. E., Lehmann, C., Lawrence, R. C., & Kelly, S. J. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.03.010 · Cited by 90
Epigenetic regulation and the pathogenesis of systemic lupus erythematosus
Pan, Y., & Sawalha, A. H. (2008) · Translational research · doi:10.1016/j.trsl.2008.10.007 · Cited by 91
Kishi, N., & Macklis, J. D. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.007 · Cited by 93
The role of neurotrophic factors in autism
Nickl‐Jockschat, T., & Michel, T. M. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.103 · Cited by 96
MicroRNAs regulate synaptic plasticity underlying drug addiction
Smith, A. C. W., & Kenny, P. J. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12424 · Cited by 91
MeCP2 modulates gene expression pathways in astrocytes
Yasui, D. H., Xu, H., Dunaway, K. W., LaSalle, J. M., Jin, L.-W., & Maezawa, I. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-3 · Cited by 90
Pacheco, N. L., Heaven, M. R., Holt, L. M., Crossman, D. K., Boggio, K. J., Shaffer, S. A., Flint, D. L., & Olsen, M. L. (2017) · Molecular Autism · doi:10.1186/s13229-017-0174-4 · Cited by 90
Biological Functions of Methyl-CpG-Binding Proteins
Defossez, P., & Stancheva, I. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387685-0.00012-3 · Cited by 102
Rett syndrome – biological pathways leading from MECP2 to disorder phenotypes
Ehrhart, F., Coort, S. L., Cirillo, E., Smeets, E., Evelo, C. T., & Curfs, L. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0545-5 · Cited by 91
Filippis, B. D., Valenti, D., Lidia de, B. A. R. I., Rasmo, D. D., Musto, M., Fabbri, A., Ricceri, L., Fiorentini, C., Laviola, G., & Vacca, R. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.014 · Cited by 95
Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets
Javaid, N., & Choi, S. (2017) · Genes · doi:10.3390/genes8080196 · Cited by 97
Cukier, H. N., Lee, J. M., Ma, D., Young, J. I., Mayo, V., Butler, B. L., Ramsook, S. S., Rantus, J. A., Abrams, A. J., Whitehead, P. L., et al. (2012) · Autism Research · doi:10.1002/aur.1251 · Cited by 89
Su, M., HONG, J., ZHAO, Y., Liu, S., & XUE, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4104 · Cited by 93
Jin, L.-W., Horiuchi, M., Wulff, H., Liu, X.-B., Cortopassi, G. A., Erickson, J. D., & Maezawa, I. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2778-14.2015 · Cited by 88
“MECP2 encodes methylCpG-binding protein 2 (MeCP2), an epigenetic modulator that binds the methyl CpG dinucleotide in target genes to regulate transcription (Amir et al., 1999; Chahrour et al., 2008).”
BackgroundRoth, T. L., Matt, S. M., Chen, K., & Blaze, J. (2014) · Developmental Psychobiology · doi:10.1002/dev.21218 · Cited by 98
Elmer, B. M., Estes, M. L., Barrow, S. L., & McAllister, A. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2366-13.2013 · Cited by 88
McCauley, M. D., Wang, T., Mike, E. V., Herrera, J. A., Beavers, D. L., Huang, T.-W., Ward, C. S., Skinner, S. A., Percy, A. K., Glaze, D. G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002982 · Cited by 87
Epigenetic mechanisms in fear conditioning: Implications for treating post-traumatic stress disorder
Kwapis, J. L., & Wood, M. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.005 · Cited by 87
Djuric, U., Cheung, A. Y. L., Zhang, W., Mok, R. S. F., Lai, W., Piekna, A., Hendry, J. A., Ross, P. J., Pasceri, P., Kim, D. S., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.01.001 · Cited by 93
Genetic and epigenetic defects in mental retardation
Kramer, J. M., & van Bokhoven, H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.009 · Cited by 91
MeCP2 Repression of G9a in Regulation of Pain and Morphine Reward
Zhang, Z., Tao, W., Hou, Y.-Y., Wang, W., Kenny, P. J., & Pan, Z. Z. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4194-13.2014 · Cited by 88
A genomic point-of-view on environmental factors influencing the human brain methylome
LaSalle, J. M. (2011) · Epigenetics · doi:10.4161/epi.6.7.16353 · Cited by 89
Webb, R. D., Wren, J. D., Jeffries, M. A., Kelly, J. A., Kaufman, K. M., Tang, Y., Frank, M. B., Merrill, J. T., Kimberly, R. P., Edberg, J. C., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24360 · Cited by 86
Regression in Rett syndrome: Developmental pathways to its onset
Einspieler, C., & Marschik, P. B. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.01.028 · Cited by 89
Rasmi, Y., Shokati, A., Hassan, A., Aziz, S. G., Bastani, S., Jalali, L., Moradi, F., & Alipour, S. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.12.002 · Cited by 89
Dynamics of DNA Methylation in Aging and Alzheimer's Disease
Irier, H. A., & Jin, P. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1565 · Cited by 85
Hirano, K., eKaneko, R., Izawa, T., Kawaguchi, M., Kitsukawa, T., & Yagi, T. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00090 · Cited by 85
iPS cells to model CDKL5-related disorders
Amenduni, M., Filippis, R. D., Cheung, A. Y. L., Disciglio, V., Epistolato, M. C., Ariani, F., Mari, F., Mencarelli, M. A., Hayek, Y., Renieri, A., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.131 · Cited by 85
A High-Resolution Imaging Approach to Investigate Chromatin Architecture in Complex Tissues
Linhoff, M. W., Garg†, S. K., & Mandel, G. (2015) · Cell · doi:10.1016/j.cell.2015.09.002 · Cited by 83
Copf, T. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.008 · Cited by 92
Yazdani, M., Deogracias, R., Guy, J., Poot, R. A., Bird, A. P., & Barde, Y. (2012) · Stem Cells · doi:10.1002/stem.1180 · Cited by 84
Elton, T. S., Sansom, S. E., & Martin, M. M. (2010) · RNA Biology · doi:10.4161/rna.7.5.12685 · Cited by 83
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
Collins, B. E., & Neul, J. L. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s371483 · Cited by 87
Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis
Chen, L., Zhang, M., Yang, X., Wang, Y., Huang, T., Li, X., Ban, Y., Li, Q., Yang, Q., Zhang, Y., et al. (2024) · Theranostics · doi:10.7150/thno.94738 · Cited by 92
Ma, Z., Jiang, W., & Zhang, E. E. (2016) · Scientific Reports · doi:10.1038/srep36035 · Cited by 79
Zhao, L., Liu, Y., Tong, D., Qin, Y., Yang, J., Xue, M., Du, N., Liu, L., Guo, B., Hou, N., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.021 · Cited by 82
Epigenetics and Psychostimulant AddictionPreprint
Schmidt, H. D., McGinty, J. F., West, A. E., & Sadri‐Vakili, G. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012047 · Cited by 82
Beery, A. K., McEwen, L. M., MacIsaac, J. L., Francis, D. D., & Kobor, M. S. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.022 · Cited by 81
Blaze, J., & Roth, T. L. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.10.001 · Cited by 86
Hwang, J.-Y., Kaneko, N., Noh, K., Pontarelli, F., & Zukin, R. S. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.032 · Cited by 84
Isoform-Specific Toxicity of Mecp2 in Postmitotic Neurons: Suppression of Neurotoxicity by FoxG1
Dastidar, S. G., Bardai, F. H., Ma, C., Price, V. J., Rawat, V., Verma, P., Narayanan, V., & D’Mello, S. R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5841-11.2012 · Cited by 81
The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome
Zeev, B. B., Bebbington, A., Ho, G., Leonard, H., de Klerk, N. H., Gak, E., Vecksler, M., & Christodoulou, J. (2009) · Neurology · doi:10.1212/01.wnl.0000345664.72220.6a · Cited by 81
Gogliotti, R. G., Senter, R. K., Fisher, N. M., Adams, J., Zamorano, R., Walker, A. G., Blobaum, A. L., Engers, D. W., Hopkins, C. R., Daniels, J. S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7459 · Cited by 80
Segatto, M., Trapani, L., Di Tunno, I., Sticozzi, C., Valacchi, G., Hayek, J., & Pallottini, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104834 · Cited by 80
MeCP2 Is Required for Normal Development of GABAergic Circuits in the Thalamus
Zhang, Z., Zak, J. D., & Liu, H. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00601.2009 · Cited by 80
study, D., Zhou, W., He, Y., Rehman, A. U., Kong, Y., Hong, S., Ding, G., Yalamanchili, H. K., Wan, Y., Paul, B., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0311-1 · Cited by 83
Lubin, F. D., Gupta, S., Parrish, R. R., Grissom, N. M., & Davis, R. L. (2011) · The Neuroscientist · doi:10.1177/1073858411386967 · Cited by 99
Epigenetic programming of neurodegenerative diseases by an adverse environment
Babenko, O., Kovalchuk, I., & Metz, G. A. S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.038 · Cited by 80
Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice
D'Cruz, J. A., Wu, C., Zahid, T., El-Hayek, Y. H., Zhang, L., & Eubanks, J. H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.018 · Cited by 80
Novel variants identified in methyl-CpG-binding domain genes in autistic individuals
Cukier, H. N., Rabionet, R., Konidari, I., Rayner‐Evans, M. Y., Baltos, M. L., Wright, H. H., Abramson, R. K., Martin, E. R., Cuccaro, M. L., Pericak‐Vance, M. A., et al. (2009) · Neurogenetics · doi:10.1007/s10048-009-0228-7 · Cited by 79
MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
Rastegar, M., Hotta, A., Pasceri, P., Makarem, M., Cheung, A. Y. L., Elliott, S., Park, K. J., Adachi, M., Jones, F. S., Clarke, I. D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006810 · Cited by 79
Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil
Felice, C. D., Signorini, C., Durand, T., Ciccoli, L., Leoncini, S., D’Esposito, M., Filosa, S., Oger, C., Guy, A., Bultel‐Poncé, V., et al. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0285-7 · Cited by 79
Invited Review: Epigenetics in neurodevelopment
Salinas, R. D., Connolly, D. R., & Song, H. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12608 · Cited by 90
Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases
Gibson, F. T., Hanly, A. M., Grbic, N., Grunberg, N., Wu, M., Collard, M., & Alani, R. M. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08956-8 · Cited by 83
Epigenetic mechanisms regulate NADPH oxidase-4 expression in cellular senescence
Sanders, Y. Y., Liu, H., Liu, G., & Thannickal, V. J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.008 · Cited by 78
Kynast, K. L., Russe, O. Q., Möser, C. V., Geißlinger, G., & Niederberger, E. (2012) · Pain · doi:10.1016/j.pain.2012.11.010 · Cited by 80
Microglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
The first mecp2-null zebrafish model shows altered motor behaviors
Pietri, T., Roman, A.-C., Guyon, N., Romano, S. A., Washbourne, P., Moens, C. B., de Polavieja, G. G., & Sumbre, G. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00118 · Cited by 85
CNV and nervous system diseases – what’s new?
Gu, W., & Lupski, J. R. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184692 · Cited by 79
Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model
Petazzi, P., Sandoval, J., Szczęsna, K., Jorge-Torres, O. C., Roa, L., Sayols, S., Gómez, A., Huertas, D., & Esteller, M. (2013) · RNA Biology · doi:10.4161/rna.24286 · Cited by 80
Developmental Dynamics of Rett Syndrome
Feldman, D., Banerjee, A., & Sur, M. (2016) · Neural Plasticity · doi:10.1155/2016/6154080 · Cited by 80
DNA Methylation and Its Implications and Accessibility for Neuropsychiatric Therapeutics
Day, J. J., Kennedy, A. J., & Sweatt, J. D. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124527 · Cited by 78
MeCP2 Represses Enhancers through Chromosome Topology-Associated DNA Methylation
Clemens, A. W., Wu, D. Y., Moore, J. R., Christian, D. L., Zhao, G., & Gabel, H. W. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.10.033 · Cited by 78
Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children
Brooks‐Kayal, A. R. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02906.x · Cited by 82
Miyake, K., Hirasawa, T., Soutome, M., Itoh, M., Goto, Y., Endoh, K., Takahashi, K., Kudo, S., Nakagawa, T., Yokoi, S., et al. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-81 · Cited by 80
Homeodomain Protein Otp and Activity-Dependent Splicing Modulate Neuronal Adaptation to Stress
Amir-Zilberstein, L., Blechman, J., Sztainberg, Y., Norton, W., Reuveny, A., Borodovsky, N., Tahor, M., Bonkowsky, J. L., Bally‐Cuif, L., Chen, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.019 · Cited by 76
Thambirajah, A. A., Ng, M. K., Frehlick, L. J., Li, A., Serpa, J. J., Petrotchenko, E. V., Silva‐Moreno, B., Missiaen, K. K., Borchers, C. H., Hall, J. A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1066 · Cited by 82
Rea, V., & Raay, T. J. V. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.575575 · Cited by 77
Metadata
- Authors
- Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Zoghbi, Huda Y.
- Venue
- Science
- Published
- 2008-05-30
- Volume
- 320
- Issue
- 5880
- Pages
- 1224-1229
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2443785
- OpenAlex
- W2039276157
- Cited by
- 1,823
- References
- 22
- Citations by year
- 2026: 53 · 2025: 55 · 2024: 76 · 2023: 67 · 2022: 84 · 2021: 95 · 2020: 96 · 2019: 90 · 2018: 69 · 2017: 131 · 2016: 133 · 2015: 113 · 2014: 131 · 2013: 153 · 2012: 128
- FWCI
- 66.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Neurological Disorders and Stroke (NS057819, R01NS057819)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 024064, P30HD024064)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MeCP2, Rett syndrome, transcriptional repression, transcriptional activation, CREB1, promoter binding, hypothalamus, gene expression profiling, neuropsychiatric disorders, neurodevelopmental disorders
- MeSH terms
- Animals, Disease Models, Animal, Gene Expression Regulation, Hypothalamic Diseases, Hypothalamus, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Nervous System Diseases, Protein Binding, Repressor Proteins, Transcription Factors, Rett Syndrome, Transcriptional Activation, Cyclic AMP Response Element-Binding Protein, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mice, Methyl-CpG-Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
